一项使用单相避孕药妈富隆的临床试验。
[A clinical trial with the monophasic contraceptive Marvelon].
作者信息
Rachev E, Damianov L, Katsarova M
出版信息
Akush Ginekol (Sofiia). 1994;33(3):44-5.
PMID:7793530
Abstract
The authors present their clinical experience with a monophasic preparation consisting of 30 mcg ethynyl estradiol and 150 mcg desogestrel (Marvelon, Organon). 121 cycles of 24 fertile women were followed. The results show a full contraceptive success, a stable cycle control as well as a low incidence of the side effects.
摘要
作者介绍了他们使用由30微克乙炔雌二醇和150微克去氧孕烯组成的单相制剂（妈富隆，欧加农公司）的临床经验。对24名育龄妇女的121个周期进行了跟踪。结果显示避孕效果完全成功，月经周期控制稳定，且副作用发生率低。
Zotero 插件